The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO 2025 | GO-PANC: longitudinal study of GI symptoms & QoL after pancreatectomy
Annuska Schoorlemmer, Amsterdam UMC, Amsterdam, Netherlands, discusses a nationwide multicenter study, known as GO-PANC, which investigates gastrointestinal symptoms and quality of life after pancreatectomy in patients with pancreatic cancer. She explains that the study, performed by nurse practitioners, aims to improve patient outcomes by managing gastrointestinal symptoms and enhancing quality of life. This interview took place at the European Society for Medical Oncology (ESMO) 2025 Congress in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
Well, actually, it’s a nationwide multicenter study performed by nurse practitioners looking into the data we collected for patients with pancreatic cancer who underwent surgery just to improve their outcomes on quality of life and how to manage gastrointestinal symptoms.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Well, actually, it’s a nationwide multicenter study performed by nurse practitioners looking into the data we collected for patients with pancreatic cancer who underwent surgery just to improve their outcomes on quality of life and how to manage gastrointestinal symptoms.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
